FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1899691766> ?p ?o ?g. }

• W1899691766 endingPage "574" @default.
• W1899691766 startingPage "567" @default.
• W1899691766 abstract "Hepatorenal syndrome (HRS), a serious complication of cirrhosis, is associated with high mortality without treatment. Terlipressin with albumin is effective in the reversal of HRS. Where terlipressin is not available, as in the United States, midodrine and octreotide with albumin are used as an alternative treatment of HRS. The aim was to compare the effectiveness of terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of HRS in a randomized controlled trial. Twenty-seven patients were randomized to receive terlipressin with albumin (TERLI group) and 22 to receive midodrine and octreotide plus albumin (MID/OCT group). The TERLI group received terlipressin by intravenous infusion, initially 3 mg/24 hours, progressively increased to 12 mg/24 hours if there was no response. The MID/OCT group received midodrine orally at an initial dose of 7.5 mg thrice daily, with the dose increased to a maximum of 12.5 mg thrice daily, together with octreotide subcutaneously: initial dose 100 μg thrice daily and up to 200 μg thrice daily. Both groups received albumin intravenously 1 g/kg of body weight on day 1 and 20-40 g/day thereafter. There was a significantly higher rate of recovery of renal function in the TERLI group (19/27, 70.4%) compared to the MID/OCT group (6/21, 28.6%), P = 0.01. Improvement in renal function and lower baseline Model for End-Stage Liver Disease score were associated with better survival. Conclusion: Terlipressin plus albumin is significantly more effective than midodrine and octreotide plus albumin in improving renal function in patients with HRS (Hepatology 2015;62:567–574" @default.
• W1899691766 created "2016-06-24" @default.
• W1899691766 creator A5002447479 @default.
• W1899691766 creator A5002609899 @default.
• W1899691766 creator A5003122029 @default.
• W1899691766 creator A5003339887 @default.
• W1899691766 creator A5006387483 @default.
• W1899691766 creator A5007434584 @default.
• W1899691766 creator A5012239800 @default.
• W1899691766 creator A5016829240 @default.
• W1899691766 creator A5023614290 @default.
• W1899691766 creator A5053249691 @default.
• W1899691766 creator A5064956279 @default.
• W1899691766 creator A5065210915 @default.
• W1899691766 creator A5066896590 @default.
• W1899691766 creator A5071502368 @default.
• W1899691766 creator A5074987527 @default.
• W1899691766 creator A5086326423 @default.
• W1899691766 creator A5089713793 @default.
• W1899691766 creator A5091563644 @default.
• W1899691766 date "2015-02-13" @default.
• W1899691766 modified "2023-10-10" @default.
• W1899691766 title "Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial" @default.
• W1899691766 cites W1228830179 @default.
• W1899691766 cites W1967589221 @default.
• W1899691766 cites W1990578976 @default.
• W1899691766 cites W2007343924 @default.
• W1899691766 cites W2011199481 @default.
• W1899691766 cites W2024929331 @default.
• W1899691766 cites W2036652612 @default.
• W1899691766 cites W2045376161 @default.
• W1899691766 cites W2045620941 @default.
• W1899691766 cites W2046700466 @default.
• W1899691766 cites W2049714815 @default.
• W1899691766 cites W2051265236 @default.
• W1899691766 cites W2051278614 @default.
• W1899691766 cites W2054641887 @default.
• W1899691766 cites W2066442380 @default.
• W1899691766 cites W2072706984 @default.
• W1899691766 cites W2074466817 @default.
• W1899691766 cites W2078113157 @default.
• W1899691766 cites W2094598763 @default.
• W1899691766 cites W2113711610 @default.
• W1899691766 cites W2120179295 @default.
• W1899691766 cites W2157556100 @default.
• W1899691766 cites W2158606074 @default.
• W1899691766 cites W2164601307 @default.
• W1899691766 cites W2214600008 @default.
• W1899691766 cites W2315027248 @default.
• W1899691766 doi "https://doi.org/10.1002/hep.27709" @default.
• W1899691766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25644760" @default.
• W1899691766 hasPublicationYear "2015" @default.
• W1899691766 type Work @default.
• W1899691766 sameAs 1899691766 @default.
• W1899691766 citedByCount "260" @default.
• W1899691766 countsByYear W18996917662015 @default.
• W1899691766 countsByYear W18996917662016 @default.
• W1899691766 countsByYear W18996917662017 @default.
• W1899691766 countsByYear W18996917662018 @default.
• W1899691766 countsByYear W18996917662019 @default.
• W1899691766 countsByYear W18996917662020 @default.
• W1899691766 countsByYear W18996917662021 @default.
• W1899691766 countsByYear W18996917662022 @default.
• W1899691766 countsByYear W18996917662023 @default.
• W1899691766 crossrefType "journal-article" @default.
• W1899691766 hasAuthorship W1899691766A5002447479 @default.
• W1899691766 hasAuthorship W1899691766A5002609899 @default.
• W1899691766 hasAuthorship W1899691766A5003122029 @default.
• W1899691766 hasAuthorship W1899691766A5003339887 @default.
• W1899691766 hasAuthorship W1899691766A5006387483 @default.
• W1899691766 hasAuthorship W1899691766A5007434584 @default.
• W1899691766 hasAuthorship W1899691766A5012239800 @default.
• W1899691766 hasAuthorship W1899691766A5016829240 @default.
• W1899691766 hasAuthorship W1899691766A5023614290 @default.
• W1899691766 hasAuthorship W1899691766A5053249691 @default.
• W1899691766 hasAuthorship W1899691766A5064956279 @default.
• W1899691766 hasAuthorship W1899691766A5065210915 @default.
• W1899691766 hasAuthorship W1899691766A5066896590 @default.
• W1899691766 hasAuthorship W1899691766A5071502368 @default.
• W1899691766 hasAuthorship W1899691766A5074987527 @default.
• W1899691766 hasAuthorship W1899691766A5086326423 @default.
• W1899691766 hasAuthorship W1899691766A5089713793 @default.
• W1899691766 hasAuthorship W1899691766A5091563644 @default.
• W1899691766 hasBestOaLocation W18996917661 @default.
• W1899691766 hasConcept C126322002 @default.
• W1899691766 hasConcept C141071460 @default.
• W1899691766 hasConcept C159641895 @default.
• W1899691766 hasConcept C2776125364 @default.
• W1899691766 hasConcept C2776297358 @default.
• W1899691766 hasConcept C2776988256 @default.
• W1899691766 hasConcept C2777214474 @default.
• W1899691766 hasConcept C2779393834 @default.
• W1899691766 hasConcept C2780081974 @default.
• W1899691766 hasConcept C2781025020 @default.
• W1899691766 hasConcept C71924100 @default.
• W1899691766 hasConcept C73787029 @default.
• W1899691766 hasConcept C84393581 @default.
• W1899691766 hasConcept C90924648 @default.

• next